INCAP, Guatemala Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Alternative names

INCAP, Guatemala

Active Ingredients

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Death (Phase 3)

Infections (Phase 3)

Maternal Death (Phase 3)

Neonatal Sepsis (Phase 3)

Perinatal Death (Phase 3)

Pregnancy Complications, Infectious (Phase 3)

Puerperal Infection (Phase 3)

Sepsis (Phase 3)

Toxemia (Phase 3)

Overview

  • Highest Phase: None
  • # of Trials: 0
  • # of Trial APIs: 0